Clinical Trials Sponsored by Mast Therapeutics, Inc.
Total 3013 results
-
Medicenna Therapeutics, Inc.CompletedGlioblastoma | Glioblastoma Multiforme | Grade IV Astrocytoma | Grade IV GliomaUnited States
-
Aileron Therapeutics, Inc.TerminatedNon Small Cell Lung Cancer | Small-cell Lung CancerUnited States, Spain, Poland, Italy, Serbia, Bosnia and Herzegovina, Germany
-
Partner Therapeutics, Inc.CompletedDrug Kinetics | Drug Effects on PhysiologyCanada
-
Aldeyra Therapeutics, Inc.Completed
-
Travere Therapeutics, Inc.CompletedHealthy SubjectsUnited Kingdom
-
Virios Therapeutics, Inc.CompletedFibromyalgiaUnited States
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Peloton Therapeutics, Inc.Active, not recruitingA Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)Kidney Cancer | Clear Cell Renal Cell Carcinoma | Glioblastoma | Solid Tumor | Glioblastoma Multiforme | Advanced Solid Tumors | GBM | Solid Tumor, Adult | Solid Carcinoma | Glioblastoma, Adult | ccRCC | RCC, Clear Cell Adenocarcinoma | RCC | Renal Cell Carcinoma, Metastatic | Renal Cell Carcinoma Recurrent | Renal Cell...
-
Edgewise Therapeutics, Inc.CompletedMuscular DystrophiesUnited States
-
DurectTherapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Eirion Therapeutics Inc.CompletedLateral Canthal Lines | Crow's FeetUnited States
-
TG Therapeutics, Inc.TerminatedB-cell Non Hodgkin Lymphoma | Richter's TransformationUnited States
-
Melinta Therapeutics, Inc.CompletedAbscess | Cellulitis | Wound Infection | Systemic InflammationUnited States
-
Carmot Therapeutics, Inc.Active, not recruitingObesity | Type2 DiabetesUnited States, Mexico
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States
-
AN2 Therapeutics, IncCompletedRenal InsufficiencyUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Onconic Therapeutics Inc.Completed
-
Click Therapeutics, Inc.WithdrawnSubstance Use Disorder | Drug Addiction | Tobacco Dependence | Drug Dependence | Nicotine AddictionUnited States
-
Onconic Therapeutics Inc.CompletedAnti-Ulcer AgentsKorea, Republic of
-
Applied Therapeutics, Inc.Active, not recruiting
-
Pipeline Therapeutics, Inc.CompletedSensorineural Hearing LossUnited States
-
Galera Therapeutics, Inc.CompletedRenal ImpairmentUnited States
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Cara Therapeutics, Inc.Approved for marketing
-
Cara Therapeutics, Inc.CompletedUremic PruritusUnited States, Canada, Czechia, Australia, Germany, Hungary, Korea, Republic of, New Zealand, Poland, Taiwan, United Kingdom
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
-
Sorrento Therapeutics, Inc.WithdrawnBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Carcinoembryonic AntigenUnited States
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
DiaMedica Therapeutics IncCompletedKidney DiseasesUnited States
-
Tobira Therapeutics, Inc.TerminatedNonalcoholic SteatohepatitisUnited States, Spain, Australia, Belgium, Israel, Canada, Puerto Rico, Italy, Germany, France, New Zealand, Taiwan, Poland, United Kingdom, Brazil, Austria, Singapore, Portugal, Chile, Greece, Hong Kong, Hungary, Latvia, Mexico, Norway, R... and more
-
Sorrento Therapeutics, Inc.Withdrawn
-
Anika Therapeutics, Inc.CompletedKnee OsteoarthritisHungary, Poland
-
Denali Therapeutics Inc.CompletedHealthy VolunteersNetherlands
-
Antios Therapeutics, IncCompletedDrug Drug InteractionCanada
-
Sorrento Therapeutics, Inc.Completed
-
Sorrento Therapeutics, Inc.Withdrawn
-
Orbus Therapeutics, Inc.Active, not recruitingAnaplastic Astrocytoma | Recurrent Anaplastic AstrocytomaUnited States, United Kingdom, France, Canada, Italy, Germany, Netherlands, Belgium
-
Vyne Therapeutics Inc.Completed
-
Vyne Therapeutics Inc.CompletedPapulopustular RosaceaUnited States
-
Biosplice Therapeutics, Inc.CompletedAndrogenetic AlopeciaTurkey
-
Regulus Therapeutics Inc.CompletedPolycystic Kidney Disease, Autosomal DominantUnited States
-
TG Therapeutics, Inc.CompletedRelapsing Multiple Sclerosis (RMS)United States
-
Palvella Therapeutics, Inc.Active, not recruitingPachyonychia CongenitaUnited States
-
Aimmune Therapeutics, Inc.Completed
-
Aimmune Therapeutics, Inc.CompletedPeanut AllergyUnited States
-
Magenta Therapeutics, Inc.CompletedInherited Metabolic Disorders (IMD)United States
-
Aimmune Therapeutics, Inc.Completed
-
Protagonist Therapeutics, Inc.TerminatedUlcerative ColitisUnited States, Australia, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czechia, Germany, Hungary, Korea, Republic of, Latvia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Ukraine